Message from the Executive Director

Who’s your #NiemannPickChampion? October is Niemann-Pick Awareness Month! These next few weeks are an especially important time to tell your family stories on your experiences with Niemann-Pick Disease. Show everyone who’s your #NiemannPickChampion! There is no better time to increase awareness of Niemann-Pick Disease and to educate friends, policy makers, clinicians, and others about this rare […]

September 2022 Newsletter

News & Events > Newsletters Message from the Executive Director  |  Niemann-Pick Awareness Month  |  Community Connections Opportunities  |  Family Support & Medical Conference Recordings  |  Cyclo Therapeutics Patient Newsletter  |  Orphanet Publication Alert  |  ASMD Accelerate  |  LinkedIn Pulse: US Approval of Xenpozyme  |  CheckRare: FDA Approves Olipudase Alfa  |  Fundraising  |  Social Services […]

NNPDF Celebrates Monumental Milestone with the First U.S. Approval for ASMD

The National Niemann-Pick Disease Foundation joins with patients and families in the U.S. and the entire global Niemann-Pick community in celebrating this historic advance in research: the first-ever U.S. approval of a treatment for ASMD! For more than 20 years, NNPDF has worked to support patients and families impacted by ASMD (acid sphingomyelinase deficiency) by […]

Summer 2022 Newsletter

News & Events > Newsletters APPROVAL! Xenpozyme for Treatment of ASMD ​  |  Community Update Series: XenpozymeMessage from the Board Chair  |  2022 Family Support & Medical Conference RecapNNPDF 2022 Awards  |  NNPDF 2022 Board of Directors |  NNPDF Welcomes New Board MembersDuke-Margolis Center Webinar  |  ASMD Accelerate  |  AllStripes UpdateACT for ALS Workshop  |  […]

June 2022 Newsletter

News & Events > Newsletters Message from the Board Chair  |  2022 Family Support & Medical ConferenceNPC Family Advisory Working Groups  |  NNPDF Community Survey  |  ASMD Community SurveyASMD Accelerate  |  Duke-Margolis Center Update  |  Milestones: Willow HemsleyINPDR Poster Presentation on NPC  |  Community News Updates |  Clinical Trial UpdatesSurveys & Studies  |  Fundraising  |  […]

In the Spotlight with Pam Andrews

Pam Andrews Mom to Belle & Abby, NPCFirefly Fund, Co-Founder and Executive Director Tell us a bit about yourself.My name is Pam Andrews. I’m a sixth generation Texan and was born in a small town just outside of Austin called Brenham, Texas. You may have heard of it before, as it’s the home of Blue […]

May 2022 Newsletter

News & Events > Newsletters 2022 Family Support & Medical ConferenceNNPDF Cora Sterling Endurance Award  | NNPDF Research Fellowship ApplicationsINPDA – ASMD Webinar Recording  |  ASMD Accelerate  |  Pfrieger’s DigestTransport NPC   |  Clinical Trial Updates  |  Community News Updates |  Surveys & Studies   Fundraising  |  Membership  |  Emergency Hardship Program NNPDF Family Support & […]

Message from NNPDF on arimoclomol

Dear NPC Community Members, This week, Orphazyme announced that they have reached an agreement with US-based pharma company KemPharm to acquire arimoclomol, the investigational drug candidate that Orphazyme had in development for the treatment of Niemann-Pick disease type C (NPC), which is schedule to officially to occur on June 1, 2022. Under the terms of […]

April 2022 Newsletter

News & Events > Newsletters Message from Executive Director  |  2022 Family Support & Medical ConferenceFamily Advisory Working Groups  |  Family Conference ScholarshipsJoele Ruppert & Joseph Colton ASMD Scholarship  |  NNPDF Cora Sterling Endurance AwardNNPDF Research Fellowship Applications  |  INPDA – ASMD Survey Webinar     Community Update Webinar Series with Sanofi – Recording  |  In […]